NDC 70771-1752 – Mirabegron

Mirabegron 25 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC70771-1752

Product details

Brand name
Mirabegron
Generic name
Mirabegron
Labeler
Zydus Lifesciences Limited
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA209488
Marketed since
January 23, 2024
Listing expires
December 31, 2026
Pharmacologic class
beta3-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Mirabegron →

Package NDC codes (3)

Package NDCDescriptionSince
70771-1752-1100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-1)Jan 23, 2024
70771-1752-330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-3)Jan 23, 2024
70771-1752-990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-9)Jan 23, 2024

Other Mirabegron products